Bicycle Conjugates to Target Solid Tumors

Time: 8:40 am
day: Day One


  • Bicycles, constrained bicyclic peptides, offer antibody-like affinity and selectivity in a small molecule format
  • Bicycle Toxin Conjugates are now in clinical development, offering rapid tumor penetration with limited plasma exposure
  • Discover how Bicycles can be used to stimulate Immuno-oncology targets such as CD137, which can be targeted to tumor cells using Bicycle tumor-targeted immune cell agonizing molecules (TICAs™)